Biocartis Group N.V.
Biocartis Group N.V. (BIOGF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOGF · as of Jun 9, 2026
Key Statistics
Explore Biocartis Group N.V. Data
biogf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
biogf competitorsBIOGF
EEOIF
GDNSF
HRPMF
KDEVF
KIARFStock Performance
Full HistoryAbout Biocartis Group N.V.
Biocartis Group N.V. is a molecular diagnostics firm dedicated to advancing clinical practice through innovative diagnostic solutions. These offerings aim to benefit patients, clinicians, healthcare p…
what is biocartis group n.v. · biogf stock overview · biocartis group n.v. company profile · who is biocartis group n.v. ceo · biogf OTC · biocartis group n.v. headquarters · biocartis group n.v. business segments
About Stock Overview & Key Data
Biocartis Group N.V. (BIOGF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Oct 14, 2021. As of the latest trading session, BIOGF stock price is $0.66, with a market capitalization of $65.4M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2022, Biocartis Group N.V. reported revenue of $57.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biocartis Group N.V. (BIOGF) stock price is $0.66. The stock is traded on OTC under the ticker symbol BIOGF. The 52-week range is $0.66 – $0.66.